It seems the diabetes world is up in arms once again. This time the debate centers around a statement from the American College of Physicians which concluded that most Type 2 diabetic patients’ A1C levels should be 7% to 8%. The group, which based its recommendation on a review of existing guidelines and clinical trials, published its guidance statement in the Annals of Internal Medicine. This statement is in sharp contrast to the widely held belief that patients should achieve an HbA1c of 7 or below.
The statement also comes at a time when many believe that HbA1c while an . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.